SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Additional Listing

4 Nov 2011 07:00

RNS Number : 4593R
BowLeven Plc
04 November 2011
 

 

 

 

 

 

 

 

 

4 November 2011

 

Bowleven plc ("Bowleven" or the "Company")

 

 

Admission of Shares to AIM

 

Application has been made for the admission of 77,500,000 new ordinary shares (the "Shares") of 10p each in the capital of Bowleven to trading on AIM. The Shares will, when issued, be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares of 10 pence each in the capital of the Company, including the right to receive all dividends and other distributions declared, made or paid on or in respect of such shares after the date of issue of the Shares.

 

These shares are being listed in connection with the issue of equity announced on 19 October 2011.

 

 

ENQUIRIES

 

For further information please contact:

 

Bowleven 00 44 131 524 5678

Kevin Hart, Chief Executive Officer

Kerry Crawford, Head of Investor Relations

 

Brunswick Group LLP 00 44 207 404 5959

Patrick Handley

Natalia Erikssen

 

BofA Merrill Lynch 00 44 207 628 1000

Andrew Osborne

Tony White

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISBJBJTMBAMBRB
Date   Source Headline
24th Sep 20247:00 amRNSCancellation - BowLeven Plc
20th Sep 20247:00 amRNSHolding(s) in Company
17th Sep 20246:00 pmRNSBowLeven
12th Sep 202410:11 amRNSResult of Exit Opportunity
28th Aug 20242:25 pmRNSResult of GM
9th Aug 20247:00 amRNSCancellation, Exit Opportunity & Notice of GM
22nd Jul 20247:00 amRNSBoard Appointment
30th May 20241:46 pmRNSBlock Admission Update
9th May 20249:52 amRNSBlock Admission Six Monthly Return
9th Apr 20243:43 pmRNSHolding(s) in Company
3rd Apr 202410:35 amRNSResults of Open Offer
2nd Apr 20241:43 pmRNSResult of General Meeting
27th Mar 20247:00 amRNSInterim Results
18th Mar 20247:54 amRNSHolding(s) in Company
15th Mar 20247:00 amRNSStandard form for notification of major holdings
14th Mar 20247:00 amRNSProposed Underwritten Open Offer to raise c$2m
12th Mar 20243:49 pmRNSHolding(s) in Company
25th Jan 202410:59 amRNSTermination of Transaction
6th Dec 20233:43 pmRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20235:47 pmRNSPosting of Annual Report and Accounts 2023
10th Nov 20237:00 amRNSFull Year Results
9th Nov 20237:00 amRNSBlock Admission Six Monthly Return
26th Sep 20237:00 amRNSCorporate Update
21st Jul 20237:00 amRNSResponse to Share Price Movement
9th May 20237:00 amRNSBlock Admission Six Monthly Return
30th Mar 20237:00 amRNSInterim Results
25th Jan 202311:00 amRNSPrice Monitoring Extension
25th Jan 20239:05 amRNSSecond Price Monitoring Extn
25th Jan 20239:00 amRNSPrice Monitoring Extension
1st Dec 202211:48 amRNSRESULT OF ANNUAL GENERAL MEETING
9th Nov 20227:00 amRNSBlock Admission Six Monthly Return
7th Nov 20227:00 amRNSPosting of Annual Report and Accounts 2022
1st Nov 20224:41 pmRNSSecond Price Monitoring Extn
1st Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20227:30 amRNSFull Year Results
18th Aug 20224:41 pmRNSSecond Price Monitoring Extn
18th Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 202211:05 amRNSSecond Price Monitoring Extn
18th Aug 202211:00 amRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSChange of Partner and Operator at Etinde Licence
13th Jun 20222:05 pmRNSSecond Price Monitoring Extn
13th Jun 20222:00 pmRNSPrice Monitoring Extension
7th Jun 202211:00 amRNSPrice Monitoring Extension
7th Jun 20227:00 amRNSChange of Partner and Operator at Etinde Licence
23rd May 20222:05 pmRNSSecond Price Monitoring Extn
23rd May 20222:00 pmRNSPrice Monitoring Extension
9th May 20228:32 amRNSBlock Admission Six Monthly Review
30th Mar 20227:00 amRNSInterim Results
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.